+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market - Global Forecast 2025-2030- Product Image
Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market - Global Forecast 2025-2030- Product Image
Sale

Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6139689
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The coronary drug-eluting stent market is experiencing a fundamental transition as advanced biomaterials and targeted drug delivery technologies support new standards of clinical care. Senior decision-makers face evolving challenges and unique market opportunities as the adoption of poly-L-lactic acid sirolimus-eluting stents accelerates, driven by innovation, supply chain adaptation, and increasingly personalized patient care strategies.

Market Snapshot: Coronary Drug-Eluting Stent Market Growth

The coronary drug-eluting stent market is shaped by rapid advancements in biodegradable scaffolds and precision-based therapies, with poly-L-lactic acid sirolimus-eluting stents gaining momentum globally. Widespread cardiovascular disease prevalence, combined with higher procedure volumes and payer interest in outcomes-driven procurement, points to significant market expansion. Manufacturers are responding to shifting healthcare economics and complex clinical requirements, making this an area of strategic focus for device makers and healthcare providers alike.

Scope & Segmentation

This report offers a comprehensive analysis of the coronary drug-eluting stent sector, mapping technological, clinical, and regional drivers. It provides granularity across operational dimensions:

  • Patient Indications: Acute coronary syndrome (non-ST-elevation MI, ST-elevation MI, unstable angina); Chronic coronary syndrome (asymptomatic, stable angina)
  • Lesion Types: De novo lesions, In-stent restenosis
  • Diameter Segments: 2.5 to 3.0 millimeter (2.5, 2.75, 3.0); greater than 3.0 millimeter (3.5, 4.0); less than 2.5 millimeter (2.25)
  • Length Options: Eighteen to twenty-eight millimeter (18, 24, 28); greater than twenty-eight millimeter (32, 38); less than eighteen millimeter (12, 16)
  • End Users: Ambulatory surgical centers, Hospitals
  • Distribution Channels: Hospital pharmacies, Online pharmacies, Specialized cardiac centers
  • Regional Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co., Ltd., Meril Life Sciences Private Limited, Reva Medical, Inc.

Key Takeaways for Decision-Makers

  • Poly-L-lactic acid sirolimus-eluting stents leverage biodegradable platforms and controlled antiproliferative drug delivery, aiming to improve vessel healing and lower late-stage complications.
  • The market is rapidly evolving with breakthroughs in polymer science, drug release mechanisms, and structural engineering, prompting a reevaluation of treatment pathways.
  • Regulatory agencies are accelerating device approvals while emphasizing the necessity for robust real-world evidence and post-market surveillance.
  • Manufacturers are localizing production in response to global economic disruptions, reducing reliance on overseas supply and strengthening domestic capabilities.
  • Integrated imaging and computational planning tools are now integral to stent selection and deployment, supporting precision therapy and better clinical results for a variety of patient and lesion types.

Tariff Impact on Market Dynamics

Recent United States tariff adjustments have introduced higher costs throughout the coronary stent supply chain, affecting everything from polymer procurement to device importation. Companies have shifted to domestic manufacturing for critical components, both to avoid tariff exposure and enhance supply chain resilience. These adjustments influence pricing strategies, negotiation with payers, and the broader interventional cardiology ecosystem. Healthcare providers have responded with adaptive procurement models, seeking to balance economic viability with sustained access to next-generation devices.

Methodology & Data Sources

Our research model integrates direct interviews with interventional cardiologists and procurement experts, quantitative analysis of clinical trial and supply data, and secondary reviews of peer-reviewed sources, regulatory filings, and field surveys. Analytical rigor is assured via triangulation, sensitivity analyses, and validation by external clinical and supply chain specialists.

Why This Report Matters

  • Enables executive leaders and procurement strategists to benchmark current and emerging device technologies for evidence-based investment decisions.
  • Provides actionable segmentation and operational insights to refine supplier negotiations and forecast future market scenarios with greater precision.
  • Supports strategic planning with robust qualitative and quantitative intelligence spanning technology, clinical practice, and regional growth trajectories.

Conclusion

The coronary drug-eluting stent market presents a dynamic landscape shaped by technology advances, regulatory shifts, and economic factors. This report equips stakeholders with clarity and strategic understanding to navigate innovation and operational complexity within the evolving realm of coronary stent therapy.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Clinical outcomes of next-generation PLLA sirolimus-eluting stents in complex bifurcation lesions under real-world practice
5.2. Innovations in polymer degradation kinetics to optimize long-term vascular healing with PLLA bioresorbable scaffolds
5.3. Impact of intravascular imaging guidance on procedural success rates for PLLA sirolimus-eluting coronary stent deployment
5.4. Comparative cost-effectiveness analyses of PLLA sirolimus-eluting stents versus durable polymer drug-eluting alternatives in emerging markets
5.5. Evolving regulatory frameworks and post-market surveillance demands for bioresorbable PLLA sirolimus-eluting stent approvals globally
5.6. Strategic partnerships between medical device companies and research institutions to accelerate IDE trials for PLLA stent platforms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market, by Indication
8.1. Introduction
8.2. Acute Coronary Syndrome
8.2.1. Non-ST-Elevation MI
8.2.2. ST-Elevation MI
8.2.3. Unstable Angina
8.3. Chronic Coronary Syndrome
8.3.1. Asymptomatic
8.3.2. Stable Angina
9. Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market, by Lesion Type
9.1. Introduction
9.2. De Novo Lesions
9.3. In-Stent Restenosis
10. Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market, by Diameter
10.1. Introduction
10.2. 2.5 to 3.0 Millimeter
10.2.1. 2.5 Millimeter
10.2.2. 2.75 Millimeter
10.2.3. 3.0 Millimeter
10.3. Greater Than 3.0 Millimeter
10.3.1. 3.5 Millimeter
10.3.2. 4.0 Millimeter
10.4. Less Than 2.5 Millimeter
10.4.1. 2.25 Millimeter
11. Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market, by Length
11.1. Introduction
11.2. Eighteen to Twenty-Eight Millimeter
11.2.1. 18 Millimeter
11.2.2. 24 Millimeter
11.2.3. 28 Millimeter
11.3. Greater Than Twenty-Eight Millimeter
11.3.1. 32 Millimeter
11.3.2. 38 Millimeter
11.4. Less Than Eighteen Millimeter
11.4.1. 12 Millimeter
11.4.2. 16 Millimeter
12. Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Hospitals
13. Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.4. Specialized Cardiac Centers
14. Americas Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. MicroPort Scientific Corporation
17.3.2. Lepu Medical Technology (Beijing) Co., Ltd.
17.3.3. Meril Life Sciences Private Limited
17.3.4. Reva Medical, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHAI
FIGURE 28. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 29. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 30. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY NON-ST-ELEVATION MI, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY NON-ST-ELEVATION MI, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ST-ELEVATION MI, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ST-ELEVATION MI, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ASYMPTOMATIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ASYMPTOMATIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STABLE ANGINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DE NOVO LESIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DE NOVO LESIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY IN-STENT RESTENOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY IN-STENT RESTENOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.75 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.75 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 3.0 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 3.0 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 3.5 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 3.5 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 4.0 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 4.0 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.25 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.25 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 18 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 18 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 24 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 24 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 28 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 28 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 32 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 32 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 38 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 38 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 12 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 12 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 16 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 16 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY SPECIALIZED CARDIAC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 163. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 166. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 167. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 168. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 169. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2018-2024 (USD MILLION)
TABLE 172. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2025-2030 (USD MILLION)
TABLE 173. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 174. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 175. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 176. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 177. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 178. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 179. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
TABLE 180. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
TABLE 181. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 182. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 183. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 184. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 185. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2018-2024 (USD MILLION)
TABLE 186. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2025-2030 (USD MILLION)
TABLE 187. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. CANADA POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 194. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 195. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 196. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 197. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2018-2024 (USD MILLION)
TABLE 200. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 202. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 203. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 204. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 206. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN 2.5 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 207. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2018-2024 (USD MILLION)
TABLE 208. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LENGTH, 2025-2030 (USD MILLION)
TABLE 209. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 210. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY EIGHTEEN TO TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 211. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2018-2024 (USD MILLION)
TABLE 212. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN TWENTY-EIGHT MILLIMETER, 2025-2030 (USD MILLION)
TABLE 213. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2018-2024 (USD MILLION)
TABLE 214. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, 2025-2030 (USD MILLION)
TABLE 215. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. MEXICO POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY ACUTE CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY CHRONIC CORONARY SYNDROME, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY LESION TYPE, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY DIAMETER, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY 2.5 TO 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL POLY-L-LACTIC ACID SIROLIMUS-ELUTING CORONARY STENT SYSTEM MARKET SIZE, BY GREATER THAN 3.0 MILLIMETER, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL POL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Poly-L-lactic Acid Sirolimus-eluting Coronary Stent System market report include:
  • MicroPort Scientific Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Private Limited
  • Reva Medical, Inc.

Related Topics

Related Reports

Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2025-2030 - Product Image

Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Rapamycin-Eluting Coronary Stent System Market - Global Forecast 2025-2030 - Product Image

Rapamycin-Eluting Coronary Stent System Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Coronary Stents Market Report 2025 - Product Image

Coronary Stents Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Bioresorbable Coronary Stents Market Size, Share & Trends Analysis Report By Material, By Drug, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Bioresorbable Coronary Stents Market Size, Share & Trends Analysis Report By Material, By Drug, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.